blog.csa.us Open in urlscan Pro
2607:f8b0:4006:822::2013  Public Scan

Form analysis
2 forms found in the DOM

GET http://www.google.com/search

<form method="get" action="http://www.google.com/search">
  <div style="border:0px solid black;padding:4px;width:20em;">
    <table border="0" cellpadding="0">
      <tbody>
        <tr>
          <td>
            <input type="text" name="q" size="15" maxlength="255" value="">
            <input type="submit" value="Search">
          </td>
        </tr>
        <tr>
          <td align="center" style="font-size:75%">
            <input type="checkbox" name="sitesearch" value="blog.csa.us" checked="">Search our Blog<br>
          </td>
        </tr>
      </tbody>
    </table>
  </div>
</form>

POST //society.csa.us/proc.php

<form method="POST" action="//society.csa.us/proc.php" id="_form_628E83D331D04_" class="_form _form_12 _inline-form  " novalidate="">
  <input type="hidden" name="u" value="628E83D331D04" data-name="u">
  <input type="hidden" name="f" value="12" data-name="f">
  <input type="hidden" name="s" data-name="s">
  <input type="hidden" name="c" value="0" data-name="c">
  <input type="hidden" name="m" value="0" data-name="m">
  <input type="hidden" name="act" value="sub" data-name="act">
  <input type="hidden" name="v" value="2" data-name="v">
  <input type="hidden" name="or" value="7aa612baf22418b7aeeaae0ecd0d6cbc" data-name="or">
  <div class="_form-content">
    <div class="_form_element _x65292546 _full_width _clear">
      <div class="_form-title"> Stay updated with the latest news and information from SCSA. </div>
    </div>
    <div class="_form_element _x38370896 _full_width ">
      <label for="firstname" class="_form-label"></label>
      <div class="_field-wrapper">
        <input type="text" id="firstname" name="firstname" placeholder="First Name" required="" data-name="firstname">
      </div>
      <!--  This STARTS the Custom Objects section  -->
    </div>
    <div class="_form_element _x31937606 _full_width ">
      <label for="lastname" class="_form-label"></label>
      <div class="_field-wrapper">
        <input type="text" id="lastname" name="lastname" placeholder="Last Name" required="" data-name="lastname">
      </div>
      <!--  This STARTS the Custom Objects section  -->
    </div>
    <div class="_form_element _x00889589 _full_width ">
      <label for="email" class="_form-label"></label>
      <div class="_field-wrapper">
        <input type="text" id="email" name="email" placeholder="Email" required="" data-name="email">
      </div>
      <!--  This STARTS the Custom Objects section  -->
    </div>
    <div class="_form_element _x64333457 _full_width ">
      <label for="phone" class="_form-label"></label>
      <div class="_field-wrapper">
        <input type="text" id="phone" name="phone" placeholder="Phone" required="" data-name="phone">
      </div>
      <!--  This STARTS the Custom Objects section  -->
    </div>
    <div class="_form_element _field9 _full_width ">
      <input type="hidden" name="field[9]" value="" data-name="source">
    </div>
    <div class="_form_element _field8 _full_width ">
      <input type="hidden" name="field[8]" value="" data-name="medium">
    </div>
    <div class="_form_element _field10 _full_width ">
      <input type="hidden" name="field[10]" value="" data-name="campaign">
    </div>
    <div class="_form_element _field11 _full_width ">
      <input type="hidden" name="field[11]" value="" data-name="term">
    </div>
    <div class="_form_element _field12 _full_width ">
      <input type="hidden" name="field[12]" value="" data-name="content">
    </div>
    <div class="_button-wrapper _full_width"><button id="_form_12_submit" class="_submit" type="submit">Subscribe to Our Newsletter</button></div>
    <div class="_clear-element"></div>
  </div>
  <div class="_form-thank-you" style="display:none;"></div>
</form>

Text Content

SEARCH OUR BLOG

Search our Blog





WEDNESDAY, MAY 25, 2022


GENETICS AFFECT DRUG REACTIONS IN OLDER ADULTS









INCREASINGLY, PATIENTS WITH ALZHEIMER’S, CANCER, DEPRESSION, CHRONIC PAIN AND
CARDIOVASCULAR DISEASE ARE GETTING GENETIC TESTING TO PERSONALIZE AND OPTIMIZE
THEIR QUALITY OF CARE.  


Pharmacogenetics, also known as pharmacogenomics, is the study of how genes
affect an individual’s response to drugs. Genetic testing searches for changes
or variations in genes that may signal which medication might be the most
effective or have fewer side effects for a particular patient.




GENOMIC TESTING

For example, scientists have been working to understand why antidepressants help
some people but don’t work for others. Humans use cytochrome P450 enzymes to
process medications. These enzymes vary in different people due to inherited
(genetic) traits, causing medications to affect each person differently. Your
doctor can use a cytochrome P450 (CYP450) test to investigate how your body
metabolizes a certain drug. The test can provide information about how you may
process different medications.


Poor metabolizers have less active or inactive alleles, which are gene
variations caused by chromosomal mutations. This places them at a higher risk of
overdosing or experiencing an increase in toxicity with some drugs. On the other
hand, ultra-rapid metabolizers can experience a lack of drug efficacy because
medicine leaves their body too quickly, before they can work as intended.
However, prodrugs such as clopidogrel and codeine can induce the opposite
reaction after metabolization.




CYP450 2D6 TESTING AVAILABLE

It is possible to get a genotyping test via the internet. PUSH Health uses a
licensed medical provider and Quest Diagnostics labs to collect information and
samples. Results are delivered electronically in about four business days for a
total of $154.51, which is typically paid privately. (Check first to see if your
health insurance provider will cover the cost of any needed testing. Some do.)


The PUSH Health website states that the test checks for proteins that may play a
role in “hormone, cholesterol and vitamin D metabolism,” and that the test can
also “help with managing dosing for medications treating mood disorders.”



Genotyping tests like CYP450 are used in other areas of medicine too. A CYP2D6
test is valuable in determining which cancer drug, such as tamoxifen for breast
cancer, is likely to be most effective for treatment. The CYP2C9 test can help
doctors pinpoint the right dose of the common blood thinner warfarin to avert
dangerous side effects. 




DRUGS OFTEN INEFFECTIVE, DANGEROUS

While 4 billion prescriptions are written every year in the US, only about half
demonstrate the expected therapeutic efficacy. Adverse drug reactions (ADRs) are
the fourth leading cause of death and cost an estimated $136 billion annually.
According to research, genetic factors can impact up to 95% of a person’s drug
response and are estimated to be a factor in up to 20% of total reported ADRs.


Furthermore, the COVID-19 pandemic forced growth in the field of personalized
care and boosted demand for pharmacogenomics, as drugs were used before FDA
approval, for compassionate use, or in clinical trials. In recent years,
regulatory agencies worldwide, including the FDA, have approved the aggregation
and dissemination of pharmacogenomic (PGx) information on hundreds of drug
labels.




USE STILL INFREQUENT

However, doctors are not always on board. In 2012, over 10,000 US physicians
conducted a nationwide survey by US physicians revealing that although 97.6% of
respondents agreed that genetic variations may influence drug response, only
10.3% felt adequately informed regarding pharmacogenomic testing. Additionally,
only 12.9% of the doctors had ordered such a test in the last six months, while
26.4% anticipated doing so in the next six months. Only 29% of all respondents
had received any education in the field. Those who had were more likely to
incorporate testing in their practice. 


A 2019 study did not find much progress. Researchers noted that 


> “in the last years, health authorities such as Health Canada and the FDA have
> set PGx biomarker information on labels of over 100 and 200 drugs,
> respectively. Despite these recommendations, the use of PGx testing in routine
> clinical care remains infrequent. Reasons that explain the slow uptake of PGx
> in clinics include unfamiliarity of health care providers with PGx, cost
> associated with testing, time constraints, absence of clear clinical
> guidelines, lack of easily accessible tests, and several ethical
> considerations."





TECHNOLOGICAL ADVANCES ENABLE GENOTYPING

It is only recently that the field of pharmacogenetics was made possible by
advances in genetic research and data gathering. Electronic medical records
(EMRs) have provided a massive influx of statistical data that has barely begun
to be mined, covering symptoms, diagnostics, biomarkers, therapy, and adverse
effects. . In the future, artificial intelligence will enhance discovery and
impact everything from medical devices to lifestyle management solutions. 


The role of PGx in therapy optimization is continuously evolving. Currently,
some applications have proven very effective. One such application is dosing for
the anticoagulant warfarin, in which 60% of individual variability in dosing can
be explained by the analysis of three enzymes, combined with an individual’s age
and weight.


In fact, a 2016 review of 80 studies found that 55% of those studies showed that
PGx testing was cost-effective, 16% demonstrated that PGx was cost-saving, and
13% showed it was cost-dominant, defined as being both cost-saving and
clinically beneficial. 


One challenge that remains is implementing PGx testing on a broader level so
that patients could present the information to healthcare professionals as a
matter of course. The goal would be to prescribe the right drug for the right
patient more often. Additionally, it would generate an enormous sum of data to
improve research outcomes and speed quality and cost-effectiveness. 


The quickest route to improved PGx testing is, in appropriate circumstances, for
patients to request it, healthcare professionals to use it, and healthcare
facilities to incorporate its use in care.

















SOURCES:

https://www.mayoclinic.org/tests-procedures/cyp450-test/about/pac-20393711
https://medlineplus.gov/genetics/understanding/genomicresearch/pharmacogenomics/
https://www.marketwatch.com/press-release/pharmacogenomics-market-2022-industry-growth-top-players-segmentation-and-forecast-to-2030-2022-03-23
https://www.futuremedicine.com/doi/10.2217/pgs-2019-0134
https://www.researchgate.net/publication/221778398_Adoption_of_Pharmacogenomic_Testing_by_US_Physicians_Results_of_a_Nationwide_Survey
https://www.nature.com/articles/s41397-021-00209-9










Blog posting provided by Society of Certified Senior Advisors


www.csa.us





Posted by Society of Certified Senior Advisors at 7:42 AM
Email ThisBlogThis!Share to TwitterShare to FacebookShare to Pinterest



Older Post Home



Stay updated with the latest news and information from SCSA.









Subscribe to Our Newsletter





BLOG ARCHIVE

 * ▼  2022 (32)
   * ▼  May (6)
     * Genetics Affect Drug Reactions in Older Adults
     * Asset Location: Which Assets Should Seniors Hold i...
     * The “Affinity Communities” Trend is Set to Explode...
     * A Tech Concierge May Increase Your Business Cateri...
     * Seniors Who Became Successful
     * Famous & 65
   * ►  April (7)
   * ►  March (7)
   * ►  February (6)
   * ►  January (6)

 * ►  2021 (74)
   * ►  December (6)
   * ►  November (6)
   * ►  October (6)
   * ►  September (7)
   * ►  August (6)
   * ►  July (7)
   * ►  June (6)
   * ►  May (6)
   * ►  April (6)
   * ►  March (6)
   * ►  February (6)
   * ►  January (6)

 * ►  2020 (77)
   * ►  December (6)
   * ►  November (6)
   * ►  October (6)
   * ►  September (7)
   * ►  August (8)
   * ►  July (6)
   * ►  June (7)
   * ►  May (7)
   * ►  April (6)
   * ►  March (6)
   * ►  February (6)
   * ►  January (6)

 * ►  2019 (73)
   * ►  December (6)
   * ►  November (6)
   * ►  October (6)
   * ►  September (6)
   * ►  August (6)
   * ►  July (6)
   * ►  June (6)
   * ►  May (6)
   * ►  April (6)
   * ►  March (6)
   * ►  February (7)
   * ►  January (6)

 * ►  2018 (75)
   * ►  December (6)
   * ►  November (5)
   * ►  October (8)
   * ►  September (7)
   * ►  August (6)
   * ►  July (6)
   * ►  June (6)
   * ►  May (6)
   * ►  April (7)
   * ►  March (6)
   * ►  February (6)
   * ►  January (6)

 * ►  2017 (122)
   * ►  December (6)
   * ►  November (6)
   * ►  October (9)
   * ►  September (9)
   * ►  August (16)
   * ►  July (13)
   * ►  June (10)
   * ►  May (12)
   * ►  April (11)
   * ►  March (11)
   * ►  February (8)
   * ►  January (11)

 * ►  2016 (112)
   * ►  December (9)
   * ►  November (11)
   * ►  October (14)
   * ►  September (11)
   * ►  August (9)
   * ►  July (9)
   * ►  June (9)
   * ►  May (8)
   * ►  April (7)
   * ►  March (8)
   * ►  February (9)
   * ►  January (8)

 * ►  2015 (83)
   * ►  December (3)
   * ►  November (3)
   * ►  October (6)
   * ►  September (8)
   * ►  August (6)
   * ►  July (9)
   * ►  June (6)
   * ►  May (7)
   * ►  April (7)
   * ►  March (10)
   * ►  February (12)
   * ►  January (6)

 * ►  2014 (56)
   * ►  December (4)
   * ►  November (5)
   * ►  October (4)
   * ►  September (4)
   * ►  August (2)
   * ►  July (7)
   * ►  June (9)
   * ►  May (6)
   * ►  April (7)
   * ►  March (3)
   * ►  February (3)
   * ►  January (2)

 * ►  2013 (39)
   * ►  December (3)
   * ►  November (2)
   * ►  October (5)
   * ►  September (4)
   * ►  August (2)
   * ►  July (2)
   * ►  June (3)
   * ►  May (1)
   * ►  April (4)
   * ►  March (3)
   * ►  February (5)
   * ►  January (5)

 * ►  2012 (68)
   * ►  December (2)
   * ►  November (5)
   * ►  October (3)
   * ►  September (5)
   * ►  August (6)
   * ►  July (5)
   * ►  June (7)
   * ►  May (4)
   * ►  April (7)
   * ►  March (7)
   * ►  February (8)
   * ►  January (9)

 * ►  2011 (94)
   * ►  December (7)
   * ►  November (8)
   * ►  October (9)
   * ►  September (7)
   * ►  August (7)
   * ►  July (9)
   * ►  June (8)
   * ►  May (7)
   * ►  April (8)
   * ►  March (6)
   * ►  February (8)
   * ►  January (10)

 * ►  2010 (41)
   * ►  December (8)
   * ►  November (8)
   * ►  October (9)
   * ►  September (12)
   * ►  August (4)







Connect with us:




Powered by Blogger.